NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...
News-Medical.Net on MSN
Human researchers still outperform AI when it comes to writing trustworthy systematic reviews
Human researchers outperformed large language models across all major stages of systematic review preparation, particularly ...
That belief underpins our manifesto for the 2026 Scottish elections, where children and young people sit firmly at the heart ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Patients in 200 mg BID cohort had median progression free survival of 6.2 months and median overall survival of 28.1 months, comparing favorably to results with other therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback